Can buspirone be used in patients with bipolar disorder?

Buspirone Should Not Be Used as Primary Treatment in Bipolar Disorder

Buspirone is not recommended for treating bipolar disorder itself, as it has no established mood-stabilizing or antimanic properties and is not included in any bipolar treatment guidelines. However, it can be cautiously used as an adjunctive agent for comorbid anxiety disorders in bipolar patients who are already adequately stabilized on mood stabilizers.

Key Evidence and Reasoning

What the Guidelines Say

The available bipolar disorder treatment guidelines 1 consistently recommend:

• First-line treatments: Lithium, valproate, and atypical antipsychotics
• Adjunctive agents for specific symptoms: Benzodiazepines for acute agitation and sleep disturbance in mania
• No mention of buspirone in any treatment algorithm for any phase of bipolar disorder

What the FDA Label States

Buspirone is FDA-approved exclusively for generalized anxiety disorder (GAD) 2. The label explicitly warns that:

• "Buspirone has no established antipsychotic activity and should not be employed in lieu of appropriate antipsychotic treatment" 2
• This is critical because it underscores buspirone lacks mood-stabilizing properties needed in bipolar disorder

Clinical Considerations

When buspirone might be considered:

• Only as adjunctive treatment for comorbid anxiety in bipolar patients
• Patient must already be on adequate mood stabilizer therapy (lithium, valproate, or atypical antipsychotic)
• Similar to how antidepressants are used: "may be useful adjuncts...as long as the patient is also taking at least one mood stabilizer" 1

Important caveats:

• Buspirone has serotonergic activity and can cause adverse effects in bipolar patients 3
• Risk of serotonin syndrome when combined with other serotonergic agents 2
• Contraindicated with MAOIs 2
• May cause discontinuation syndrome if stopped abruptly 3
• Dose-dependent adverse effects like gynecomastia have been reported in bipolar patients 3

Practical Algorithm

If considering buspirone in a bipolar patient:

1. Ensure bipolar disorder is adequately controlled first

   • Patient on therapeutic dose of mood stabilizer (lithium, valproate, or atypical antipsychotic)
   • No current manic, hypomanic, or mixed symptoms
   • Mood stability maintained for reasonable period

2. Confirm comorbid anxiety disorder diagnosis

   • GAD symptoms distinct from bipolar mood symptoms
   • Anxiety persists despite mood stabilization

3. Start low, go slow

   • Begin 5-10 mg twice daily
   • Monitor closely for mood destabilization
   • Watch for serotonergic adverse effects

4. Never use buspirone as monotherapy in bipolar disorder

Common Pitfalls to Avoid

• Do not use buspirone to treat agitation in acute mania - benzodiazepines are preferred for this indication 1
• Do not substitute buspirone for mood stabilizers - it has no antimanic or mood-stabilizing properties 2
• Do not combine with multiple serotonergic agents without careful monitoring for serotonin syndrome 2
• Do not assume anxiety symptoms are separate from bipolar disorder - they may be part of the mood episode itself

The research evidence on buspirone in bipolar disorder is extremely limited, with only one small study examining its effects on prolactin response in mania 4, which found no therapeutic benefit. The absence of buspirone from all major bipolar treatment guidelines 5, 6, 7 further confirms it has no established role in managing the disorder itself.